Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306179699> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4306179699 endingPage "E207" @default.
- W4306179699 startingPage "E205" @default.
- W4306179699 abstract "HomeRadioGraphicsVol. 42, No. 7 PreviousNext Chest ImagingInvited Commentary: Pearls and Pitfalls in Imaging Evaluation of Lung Cancer ImmunotherapyMizuki Nishino Mizuki Nishino Author AffiliationsFrom the Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215.Address correspondence to the author (email: [email protected]).Mizuki Nishino Published Online:Oct 14 2022https://doi.org/10.1148/rg.220170MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In References1. Shroff GS, Strange CD, Ahuja J, et al. Imaging of Immune Checkpoint Inhibitor Immunotherapy for Non–Small Cell Lung Cancer. RadioGraphics 2022;42(7):1956–1974. Link, Google Scholar2. Wolchok JD, Hoos A, O'Day S, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res 2009;15(23):7412–7420. Crossref, Medline, Google Scholar3. Champiat S, Dercle L, Ammari S, et al. Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1. Clin Cancer Res 2017;23(8):1920–1928. Crossref, Medline, Google Scholar4. Tirumani SH, Ramaiya NH, Keraliya A, et al. Radiographic Profiling of Immune-related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab. Cancer Immunol Res 2015;3(10):1185–1192. Crossref, Medline, Google Scholar5. Nishino M, Ramaiya NH, Hatabu H, Hodi FS. Monitoring Immune-Checkpoint Blockade: Response Evaluation and Biomarker Development. Nat Rev Clin Oncol 2017;14(11):655–668. Crossref, Medline, Google Scholar6. Nishino M, Giobbie-Hurder A, Gargano M, Suda M, Ramaiya NH, Hodi FS. Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements. Clin Cancer Res 2013;19(14):3936–3943. Crossref, Medline, Google Scholar7. Nishino M, Hong F, Ricciuti B, Hatabu H, Awad MM. Tumor Response Dynamics During First-Line Pembrolizumab Therapy in Patients With Advanced Non-Small-Cell Lung Cancer. JCO Precis Oncol 2021;5(5):501–509. Crossref, Google Scholar8. Nishino M, Giobbie-Hurder A, Hatabu H, Ramaiya NH, Hodi FS. Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis. JAMA Oncol 2016;2(12):1607–1616. Crossref, Medline, Google Scholar9. Nishino M, Sholl LM, Hodi FS, Hatabu H, Ramaiya NH. Anti-PD-1-Related Pneumonitis During Cancer Immunotherapy. N Engl J Med 2015;373(3):288–290. Crossref, Medline, Google Scholar10. Naidoo J, Reuss JE, Suresh K, et al. Immune-Related (IR)-Pneumonitis During the COVID-19 Pandemic: Multidisciplinary Recommendations for Diagnosis and Management. J Immunother Cancer 2020;8(1):e000984. Crossref, Medline, Google ScholarArticle HistoryReceived: July 7 2022Accepted: July 8 2022Published online: Oct 14 2022Published in print: Nov 2022 FiguresReferencesRelatedDetailsAccompanying This ArticleImaging of Immune Checkpoint Inhibitor Immunotherapy for Non–Small Cell Lung CancerOct 14 2022RadioGraphicsRecommended Articles Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer CareRadioGraphics2017Volume: 37Issue: 5pp. 1371-1387Immune Checkpoint Inhibitor Therapy–related Pneumonitis: Patterns and ManagementRadioGraphics2019Volume: 39Issue: 7pp. 1923-1937Imaging of Immune Checkpoint Inhibitor Immunotherapy for Non–Small Cell Lung CancerRadioGraphics2022Volume: 42Issue: 7pp. 1956-1974Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner SocietyRadiology2021Volume: 298Issue: 3pp. 550-566Imaging of Precision Therapy for Lung Cancer: Current State of the ArtRadiology2019Volume: 293Issue: 1pp. 15-29See More RSNA Education Exhibits What Should We Know About Immunotherapy And Pulmonary Reactions?Digital Posters2021From Gemcitabine, through Checkpoint Inhibitors to CAR T Cell - Evolution of Managing Treatment Related Pneumonitis in Cancer: Beyond DiagnosisDigital Posters2022Imaging Of Immunotherapy In NSCLCDigital Posters2021 RSNA Case Collection Bleomycin induced lung toxicityRSNA Case Collection2021Evolving COVID-19 pneumoniaRSNA Case Collection2020Diffuse idiopathic pulmonary neuroendocrine cell hyperplasiaRSNA Case Collection2020 Vol. 42, No. 7 Abbreviations Abbreviations: ICI immune checkpoint inhibitor irAE immune-related adverse event NSCLC non–small cell lung cancer PD-1 programmed cell death protein 1 PD-L1 programmed cell death ligand 1 RECIST Response Evaluation Criteria in Solid Tumors Metrics Altmetric Score PDF download" @default.
- W4306179699 created "2022-10-14" @default.
- W4306179699 creator A5069854182 @default.
- W4306179699 date "2022-11-01" @default.
- W4306179699 modified "2023-10-03" @default.
- W4306179699 title "Invited Commentary: Pearls and Pitfalls in Imaging Evaluation of Lung Cancer Immunotherapy" @default.
- W4306179699 cites W2100158834 @default.
- W4306179699 cites W2122096722 @default.
- W4306179699 cites W2153778867 @default.
- W4306179699 cites W2508205285 @default.
- W4306179699 cites W2554618897 @default.
- W4306179699 cites W2725398806 @default.
- W4306179699 cites W3036659746 @default.
- W4306179699 cites W3138807112 @default.
- W4306179699 cites W4306179674 @default.
- W4306179699 cites W865168492 @default.
- W4306179699 doi "https://doi.org/10.1148/rg.220170" @default.
- W4306179699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36240078" @default.
- W4306179699 hasPublicationYear "2022" @default.
- W4306179699 type Work @default.
- W4306179699 citedByCount "0" @default.
- W4306179699 crossrefType "journal-article" @default.
- W4306179699 hasAuthorship W4306179699A5069854182 @default.
- W4306179699 hasConcept C121608353 @default.
- W4306179699 hasConcept C126322002 @default.
- W4306179699 hasConcept C143998085 @default.
- W4306179699 hasConcept C203014093 @default.
- W4306179699 hasConcept C2775949291 @default.
- W4306179699 hasConcept C2776256026 @default.
- W4306179699 hasConcept C2777658100 @default.
- W4306179699 hasConcept C2777701055 @default.
- W4306179699 hasConcept C2779473830 @default.
- W4306179699 hasConcept C2780030458 @default.
- W4306179699 hasConcept C2780851360 @default.
- W4306179699 hasConcept C502942594 @default.
- W4306179699 hasConcept C55493867 @default.
- W4306179699 hasConcept C71924100 @default.
- W4306179699 hasConcept C86803240 @default.
- W4306179699 hasConcept C8891405 @default.
- W4306179699 hasConceptScore W4306179699C121608353 @default.
- W4306179699 hasConceptScore W4306179699C126322002 @default.
- W4306179699 hasConceptScore W4306179699C143998085 @default.
- W4306179699 hasConceptScore W4306179699C203014093 @default.
- W4306179699 hasConceptScore W4306179699C2775949291 @default.
- W4306179699 hasConceptScore W4306179699C2776256026 @default.
- W4306179699 hasConceptScore W4306179699C2777658100 @default.
- W4306179699 hasConceptScore W4306179699C2777701055 @default.
- W4306179699 hasConceptScore W4306179699C2779473830 @default.
- W4306179699 hasConceptScore W4306179699C2780030458 @default.
- W4306179699 hasConceptScore W4306179699C2780851360 @default.
- W4306179699 hasConceptScore W4306179699C502942594 @default.
- W4306179699 hasConceptScore W4306179699C55493867 @default.
- W4306179699 hasConceptScore W4306179699C71924100 @default.
- W4306179699 hasConceptScore W4306179699C86803240 @default.
- W4306179699 hasConceptScore W4306179699C8891405 @default.
- W4306179699 hasIssue "7" @default.
- W4306179699 hasLocation W43061796991 @default.
- W4306179699 hasLocation W43061796992 @default.
- W4306179699 hasOpenAccess W4306179699 @default.
- W4306179699 hasPrimaryLocation W43061796991 @default.
- W4306179699 hasRelatedWork W1963731933 @default.
- W4306179699 hasRelatedWork W2508091393 @default.
- W4306179699 hasRelatedWork W2596919342 @default.
- W4306179699 hasRelatedWork W3036388348 @default.
- W4306179699 hasRelatedWork W3171615116 @default.
- W4306179699 hasRelatedWork W3215044659 @default.
- W4306179699 hasRelatedWork W3216801484 @default.
- W4306179699 hasRelatedWork W4206840735 @default.
- W4306179699 hasRelatedWork W4313373552 @default.
- W4306179699 hasRelatedWork W4360983034 @default.
- W4306179699 hasVolume "42" @default.
- W4306179699 isParatext "false" @default.
- W4306179699 isRetracted "false" @default.
- W4306179699 workType "article" @default.